Reflect Scientific Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Reflect Scientific Inc (RSCF) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Reflect Scientific Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 2M vs 109,526M combined for its competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+37.1% annualized vs trailing 12 months), vs decelerating (-9.8%) for its tracked peer group.
- Growth: Reflect Scientific Inc generated 374.4% revenue growth year over year in Q2 2024, vs -7.9% for its competitors combined.
- Profitability: Its 18.5% net margin compares with -3.6% for the peer group.
- Scale: Reflect Scientific Inc ranks #27 of 32 companies by market capitalization in the Laboratory Analytical Instruments industry, holding 0.0% of industry market cap.
- Peer revenue share: Reflect Scientific Inc accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.04M compares with $0.40M for the peer group (0.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
RSCF Sales vs. its Competitors, Q2 2024
Reflect Scientific Inc reported revenue growth of 374.39 % year on year in Q2 2024, above its competitors' combined revenue change of -7.88 %.
With a net margin of 18.47 %, Reflect Scientific Inc achieved higher profitability than its competitors (-3.62 %).
Reflect Scientific Inc generated 0.00 % of the combined sales of its peer group, up from 0.00 % a year earlier.
API endpoints for this dataset
Reflect Scientific Inc vs. its Competitors, Q2 2024
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Reflect Scientific Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Reflect Scientific Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Reflect Scientific Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (5) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (4) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Reflect Scientific Inc's competitor groups requires a Commercial License.
For context: the Laboratory Analytical Instruments industry grew revenue 13.0% year over year, combined, vs 374.4% for Reflect Scientific Inc. Reflect Scientific Inc's share of combined industry revenue moved from 0.00% to 0.01%, a gain of 0.00 percentage points.
Reflect Scientific Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Reflect Scientific Inc | Yes | Yes | Yes | No |
| Competitors combined (19) | ||||
| Similar-Size Competitors (6) | ||||
| Similar Growth & Profitability (8) | 25.00 % (2 of 8) | 100.00 % (8 of 8) | 87.50 % (7 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
RSCF Stock Performance relative to its Competitors
RSCF Stock Performance relative to Similar-Size Competitors
RSCF Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Neogen Corporation | 282.9% | Outperformed |
| 2 | Illumina Inc | 282.9% | Outperformed |
| 3 | Revvity Inc | 282.9% | Outperformed |
| 4 | Bruker Corporation | 282.9% | Outperformed |
| 5 | Cytek Biosciences Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Reflect Scientific Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Publicly Traded Peers of Reflect Scientific Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Reflect Scientific Inc |
5.09 | 1.72 |
 Thermo Fisher Scientific Inc |
267,724.73 | 47,351.00 |
 Danaher Corporation |
166,182.82 | 25,608.00 |
 Agilent Technologies inc |
50,988.11 | 7,372.00 |
 Mettler toledo International Inc |
35,538.66 | 4,133.88 |
 Illumina Inc |
34,000.12 | 4,538.00 |
| SUBTOTAL | 632,164.08 | 109,768.34 |
Sign in to see all competitors of Reflect Scientific Inc.
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Reflect Scientific Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Reflect Scientific Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Thermo Fisher Scientific Inc | Clinical Research 20.15 % |
| Danaher Corporation | Diagnostics 43.97 % |
| Agilent Technologies inc | Agilent CrossLab 41.36 % |
| Mettler toledo International Inc | US Operations 35.68 % |
| Illumina Inc | Sequencing 90.43 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Reflect Scientific Inc.
Reflect Scientific Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Reflect Scientific Inc | 5 | 38,259 | 6,657 |
| Thermo Fisher Scientific Inc | 267,725 | 378,808 | 56,712 |
| Danaher Corporation | 166,183 | 426,800 | 72,183 |
| Agilent Technologies inc | 50,988 | 407,293 | 79,558 |
| Mettler toledo International Inc | 35,539 | 249,029 | 54,555 |
| Illumina Inc | 34,000 | 3,545,313 | 699,219 |
| PEERS TOTAL | 632,159 | 397,973 | 58,791 |
Sign in to see all peers for Reflect Scientific Inc.
Reflect Scientific Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Reflect Scientific Inc | International 58.90 % |
| Thermo Fisher Scientific Inc | North America 51.63 % |
| Danaher Corporation | North America 41.81 % |
| Agilent Technologies inc | Americas 41.63 % |
| Mettler toledo International Inc | Us Operations segment 35.68 % |
| Illumina Inc | United States and Canada 56.42 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Reflect Scientific Inc.
Reflect Scientific Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 28 companies in Reflect Scientific Inc's industry classification, broader than the peer set above. Market cap in millions of $.Reflect Scientific Inc ranks #27 of 28 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,503, indicating a moderately concentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Agilent Technologies inc | 50,988 | 22.21 % |
| 2 | Waters Corporation | 46,814 | 20.40 % |
| 3 | Mettler toledo International Inc | 35,539 | 15.48 % |
| 4 | Illumina Inc | 33,779 | 14.72 % |
| 5 | Revvity Inc | 1,234 | 5.2% |
| 6 | Avantor Inc | 1,234 | 5.2% |
| 7 | Bio rad Laboratories Inc | 1,234 | 5.2% |
| 8 | Bruker Corporation | 1,234 | 5.2% |
| 9 | 10x Genomics Inc | 1,234 | 5.2% |
| 10 | Alamar Biosciences Inc | 1,234 | 5.2% |
| 27 | Reflect Scientific Inc | 5 | 0.00 % |
Market cap and industry share for the rest of Reflect Scientific Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-06.
Reflect Scientific Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 22 | Eyepoint Inc | 31 | -97.28 % |
| 23 | Bionano Genomics Inc | 13 | -29.19 % |
| 24 | Lifeloc Technologies Inc | 10 | - |
| 25 | Astrotech Corp | 1,234 | 12.3% |
| 26 | Scientific Industries Inc | 1,234 | 12.3% |
| 27 | Reflect Scientific Inc | 5 | - |
| 28 | Thermogenesis Holdings Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Reflect Scientific Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-11-09. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Reflect Scientific Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Laboratory Analytical Instruments industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (49 companies). See the full Laboratory Analytical Instruments industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 58.47 % | 34.50 % (avg) | +24.0 pp |
| Operating Margin | -3.63 % | industry median | +29.0 pp |
| EBITDA Margin | 2.44 % | -12.73 % (avg) | +15.2 pp |
| Capital Intensity (Capex / Revenue) | 0.00 % | 3.87 % (avg) | -3.9 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Reflect Scientific Inc's Valuation vs Competitive Position
Valuation multiples vs the Laboratory Analytical Instruments industry average (49 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Laboratory Analytical Instruments industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 33.2x | - |
| EV / EBITDA | 88.0x | 20.6x | +67.4x |
| P/B | 2.5x | 2.9x | -0.5x |
| Return on Equity | 15.36 % | industry aggregate | 15.49 % |
| Return on Invested Capital | -1.56 % | -10.58 % (avg) | 9.02 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Reflect Scientific Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | -32.11 % | 14.58 % | -10.33 % | 45.62 % | 3.69 % | 99.65 % | -27.48 % | -47.08 % |
| Operating Margin | -44.34 % | -21.17 % | -37.74 % | -16.04 % | -12.11 % | 34.14 % | 4.41 % | -43.26 % |
| Return on Invested Capital | -72.37 % | -20.48 % | -35.78 % | -23.33 % | -18.57 % | 27.40 % | 1.88 % | -11.37 % |
| P/E | - | - | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Reflect Scientific Inc's Strategic Group Map
Reflect Scientific Inc is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
Reflect Scientific Inc's trailing-12-month revenue growth of 25.6% and operating margin of -3.6% compares with an average of 14.7% growth and -6.2% margin across its 8 closest peers by combined growth, margin and ROIC -- Reflect Scientific Inc sits above that peer average on growth and above it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Reflect Scientific Inc's BCG Growth-Share Matrix
See Methodology: BCG Growth-Share Matrix for how relative share and growth are calculated and thresholded.
Reflect Scientific Inc falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 4.2% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Reflect Scientific Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | Moderate | Industry HHI of 1,503 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 0.00 % vs industry average 3.87 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Reflect Scientific Inc's dedicated Suppliers and Customers pages, not here.
Reflect Scientific Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Reflect Scientific Inc falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Reflect Scientific Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 29.0 points above the industry median.
- Return on equity 15.5 points above the industry aggregate.
- Latest-quarter revenue run-rate is accelerating (+37.1% annualized vs trailing 12 months).
Weaknesses
- Low relative market share vs the industry leader (0.00x).
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-9.8% annualized).
Methodology: see Methodology: SWOT Analysis.
Reflect Scientific Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Reflect Scientific Inc | 2.75 | 5.55 | 0.00 |
| Thermo Fisher Scientific Inc | 0.39 | 1.69 | 0.81 |
| Danaher Corporation | - | 1.75 | 0.45 |
| Agilent Technologies inc | 0.77 | 2.02 | 1.02 |
| Mettler toledo International Inc | 0.04 | 1.13 | - |
| Illumina Inc | - | 2.02 | 0.68 |
Sign in to see all peers for Reflect Scientific Inc.
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Reflect Scientific Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Reflect Scientific Inc | Q2 2024 | -2.3 % | +27.4 % |
| Thermo Fisher Scientific Inc | Q3 2026 | +9.1 % | +6.2 % |
| Danaher Corporation | Q3 2026 | +8.3 % | +36.0 % |
| Agilent Technologies inc | Q2 2026 | +8.1 % | +7.7 % |
| Mettler toledo International Inc | Q2 2026 | +4.5 % | +15.1 % |
| Illumina Inc | Q3 2026 | +4.2 % | +46.7 % |
| PEERS TOTAL | +7.9 % | +90.4 % |
Sign in to see all peers for Reflect Scientific Inc.
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Reflect Scientific Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Reflect Scientific Inc | Q2 2024 | -4.9 % | - |
| Thermo Fisher Scientific Inc | Q3 2026 | +133.0 % | +8.2 % |
| Danaher Corporation | Q3 2026 | +7.4 % | -12.7 % |
| Agilent Technologies inc | Q2 2026 | -1.6 % | -22.3 % |
| Mettler toledo International Inc | Q2 2026 | +30.3 % | +16.4 % |
| Illumina Inc | Q3 2026 | -14.8 % | +29.0 % |
Sign in to see all peers for Reflect Scientific Inc.
Reflect Scientific Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Reflect Scientific Inc | 11.97% | 14.52% | 15.36% |
| Thermo Fisher Scientific Inc | 6.29% | 7.46% | 13.32% |
| Danaher Corporation | 4.91% | 5.57% | 8.18% |
| Agilent Technologies inc | 10.97% | 19.84% | 41.99% |
| Mettler toledo International Inc | 24.86% | 34.41% | - |
| Illumina Inc | 13.43% | 18.74% | 31.45% |
Sign in to see all peers for Reflect Scientific Inc.
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Reflect Scientific Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Reflect Scientific Inc | - | 2.96 |
| Thermo Fisher Scientific Inc | 38.14 | 5.65 |
| Danaher Corporation | 38.54 | 6.49 |
| Agilent Technologies inc | 35.54 | 6.92 |
| Mettler toledo International Inc | 39.81 | 8.60 |
| Illumina Inc | 38.13 | 7.49 |
| PEERS AVERAGE | 38.98 | 5.76 |
Sign in to see all peers for Reflect Scientific Inc.
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.